Artificial intelligence is advancing rapidly — and Singapore is actively contributing to shaping its future in healthcare. From 20 to 24 April 2026, members from Technical Committee on Healthcare and Health Informatics (TC-HCHI) and the Working Group on AI in Healthcare (WG-AI) joined the national delegation to the 53rd meeting of ISO/IEC JTC 1/SC 42/JWG 3 — the joint working group on AI-enabled Health Informatics, convened jointly by ISO/IEC JTC 1/SC 42 (Artificial Intelligence) and ISO/TC 215 (Health Informatics). Held in Singapore and bringing together more than 250 international experts both in person and online, the plenary was one of the largest gatherings of the working group to date. Singapore’s delegation engaged directly with peers from across the world on the technical work that will define how AI systems are built, governed, and trusted in real-world healthcare settings.
A Foundational Week for Global AI-in-Health Standards
The week’s agenda underscored just how broad the international standardisation effort on AI in healthcare has become. Discussions advanced foundational work on terminology and concepts for AI in healthcare, progressed a state-of-the-art technical report on the application of AI technologies in health informatics toward publication, and opened detailed deliberations on three of the most pressing frontiers in the field: the safety and reliability of generative AI, the identification and treatment of bias in healthcare AI systems, and the organisational readiness required for healthcare delivery organisations to adopt AI responsibly.
Several work items reached important inflection points during the meeting. Working drafts on generative AI — covering both classification and use cases, and a dedicated evaluation framework for safety and reliability — were reviewed by the joint working group and judged ready to progress to the next stage. New project proposals on AI applications in home healthcare and on patient-oriented healthcare agents were also tabled, signalling an expanding scope of work that increasingly reaches beyond clinical settings into community and consumer-facing healthcare AI.
Singapore’s Voice in a Critical Conversation
For Singapore, participation in JWG 3 is strategically significant. As discussed at the recent TC-HCHI meeting, Singapore’s international engagement is being deliberately focused on domains where local expertise can credibly elevate national work onto the international stage — and AI in health is at the top of that list. The Singapore-based plenary provided a rare opportunity for local experts to engage face-to-face with project editors, convenors, and national body representatives shaping the global agenda — reinforcing the value of moving from observer to active contributor in international standardisation forums.
An Invitation to Contribute
The momentum is building, and the next phase of work will benefit from broader Singapore representation. CoRE-SDO warmly invites Singapore-based subject matter experts — from healthcare delivery organisations, regulators, industry, and academia — to join the national delegation and contribute to the following international ISO project teams:
- PWI TS 26313 — Classification and Use Cases of Generative AI in Healthcare
- PWI 26319 — Evaluation Framework for Safety and Reliability of Generative AI in Healthcare
- AWI TS 26312 — Information technology — Artificial Intelligence — Identification and treatment of bias in AI by healthcare organisations
- AWI 22989-2 — Artificial Intelligence — Concepts and terminology — Part 2: Healthcare
- CD TR 18988 — Artificial Intelligence — Application of AI technologies in health informatics
- Technical Specification — Readiness framework criteria for AI adoption by healthcare delivery organisations
- Technical Specification — Guidance on implementation of 42001 in healthcare delivery organisations
These projects cover the full lifecycle of AI in healthcare — from shared terminology and foundational guidance, to bias and safety evaluation, to the operational readiness frameworks that healthcare delivery organisations will rely on as adoption accelerates. Singapore’s continued engagement in this work is an opportunity not only to shape standards that will be applied globally, but to ensure that local clinical, regulatory, and industry perspectives are reflected in the frameworks that will govern AI in healthcare for years to come.
Experts interested in joining the national delegation or learning more about any of the work items above are encouraged to reach out to CoRE-SDO by completing this nomination form.
The future of AI-enabled healthcare is being architected now — and Singapore has a seat at the table.